Rapid increase in zygomycosis in corona patients in India, drug shortage 52 deaths in western province
"Black fungi" are caused by Mucor fungi found on moist surfaces / BSIP / Universal Images Group Editorial / Getty Images
(CNN) Mucormycosis, a rare infectious disease in various parts of India, is increasing among people infected with the new coronavirus, and there is a shortage of therapeutic agents. At least 52 people have died in western Maharashtra, and health officials are becoming more cautious.
The infection, also known as the "black fungus," has occurred in India before the outbreak of the new corona, but has recently seen a surge in cases among patients with the new corona and those who have just recovered.
The disease is caused by fungi in a sweltering environment and attacks the airways of people, especially those with a weakened immune system.
Approximately 2,000 people have been recorded in Maharashtra, where the new corona is rampant, officials said. "There are an average of 100 cases a day," said a state health official, who said the antifungal drug amphotericin B was being supplied, but was initially in short supply.
The state ordered 100,000 vials. In addition, Uttar Pradesh, Madhya Pradesh, and the Federal District of Delhi are seeking the supply of medicines.
In western Gujarat, north of Maharashtra, the High Court issued an order warning of a surge in the number of cases, noting that "insufficient administration and treatment costs are also issues that the state should seriously and urgently consider." The state also ordered 100,000 vials.
The country's Ministry of Chemicals and Fertilizers said the demand for this drug, which is manufactured domestically, is skyrocketing and is making every effort to reach the patients in need.
Medical officials say the immune system is weakened or some new corona patients with underlying disorders such as diabetes appear to be infected with mucormycosis. Some have pointed out the relationship with the humidifier used to administer oxygen to patients.